FDA Approves Ozempic for Type 2 Diabetes
Novo Nordisk drug also found to help with weight loss
Different Weight Loss Patterns Observed Following Bariatric Sx
Mean weight loss of 38.2 kg (28.4 percent), 18.8 kg (14.9 percent) seven years after RYGB, LAGB
Link Between Diabetes, Antibiotic Use Called Into Question
Clinical, lifestyle factors may have confounded previous findings linking antibiotics, diabetes risk
CVS-Aetna Merger Has Implications for Doctors’ Offices
More health services will likely move out of doctors' offices to store-based providers
Remission of Type 2 Diabetes Feasible for Primary Care
Implementation of intensive weight management program linked to remission in 46 percent of patients
Adherence to T2DM Treatment Varies Across Medication Classes
Adherence better for sulfonylureas and thiazolidinediones compared with metformin
Specialty Care Tied to Reduced Mortality in New-Onset A-Fib
Finding despite increased rates of hospitalizations and other cardiovascular outcomes
November 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2017. This roundup includes...
Fat Intake Influences HbA1c-Lowering Effect in DPP4i Therapy
Saturated fat intake is significantly correlated with change in HbA1c during DPP4i monotherapy
Almonds With/Without Chocolate May Improve Lipid Profiles
Findings based on a small study assessing diet combinations in overweight people
